黑料网

Dr. Truong successfully defending his thesis on "The Roles of APOBEC3 Enzymes in Urothelial Carcinoma" under the guidance of William Y. Kim, M.D., on October 10.

Dr. Effinger successfully defended his thesis on 鈥淪ex-Specific Effects of Psychedelic Drug Administration on Stress-Related Brain Region Reactivity and Threat Responding" Nov. 7.

Dr. LIttle successfully defended her thesis, 鈥淒etermination of cross-species immune responses from outer membrane vesicle-based meningococcal vaccines to Neisseria gonorrhoeae," under the guidance of Alex Duncan, MD, PhD, on October 17.

Dr. Graboski successfully defending her thesis, 鈥淐haracterization and Inhibition of Gut Microbial Tryptophanase and its Implications in Chronic Kidney Disease" on September 21.

Zoe McElligott, PhD, was one of three 黑料网 addiction medicine researchers featured in Vital Signs. This translational research team is battling the opioid epidemic by analyzing the ever-changing composition of street drugs and testing how emerging drug combination such as xylazine and fentanyl interact in rodent models.

Dr. Sandroni,聽of聽Brian Jensen's Lab, successfully defended his PhD thesis, "The Alpha-1A Adrenergic Receptor Regulates Oxidative Metabolism in the Mouse Heart" on June 26.

Congratulations to Graydon (Grey) Gereau, graduate student from the McElligott lab, on his FIRST first-author paper exploring neurotensin transmission through the brain-body connection!

The competitive award will fund their project titled, "Development of a Novel Platform Approach to Expand the Degradable Proteome." Congratulations to all!

Dr. Altinok鈥痵uccessfully defended her thesis鈥�鈥淒omain-Specific Changes in CHIP Function Explain Distinct Clinical Features in SCA48 Patients鈥濃�痮n June 6.